Characteristics | Total patients (N = 1323) | |
---|---|---|
Age, mean (SD) | 48.7 (16.3) | |
Sex (female), N (%) | 1049 (79.3) | |
Race, N (%) | White | 882 (66.7) |
Hispanic or Latino | 72 (5.4) | |
Black or African American | 65 (4.9) | |
Asian | 34 (2.6) | |
Othera | 106 (11.9) | |
Missing | 164 (12.4) | |
Insurance, N (%) | Medicare | 205 (15.5) |
Private | 557 (42.1) | |
Medicaid | 43 (3.2) | |
Otherb | 75 (5.7) | |
Missing | 443 (33.5) | |
U.S. geographic division, N (%) | East North Central | 22 (1.7) |
West North Central | 153 (11.6) | |
Mid-Atlantic | 159 (12.0) | |
Mountain | 109 (8.2) | |
New England | 396 (29.9) | |
Pacific | 116 (8.8) | |
South Atlantic | 153 (11.6) | |
East South Central | 62 (4.7) | |
West South Central | 144 (10.9) | |
Missing | < 10 | |
Comorbidities, N (%) | Osteoporosis | 155 (11.7) |
Hypertension | 117 (8.8) | |
Hyperlipidemia | 62 (4.7) | |
Cerebrovascular accidents /TIA | 51 (3.7) | |
Diabetes mellitus | 48 (3.6) | |
Charlson comorbidity index score, mean (SD) | 0.55 (1.0) | |
Charlson comorbidity index score | ||
1 | 339 (25.6) | |
≥ 2 | 123 (9.3) | |
Clinical characteristics | Number of visits in RISE, median (IQR) | 4.5 (2.5, 8) |
Duration of follow-up time (years), median (IQR) | 2.5 (0.9, 4.4) |